Higher dose eye injection could mean fewer shots for wet AMD patients

This study is testing whether switching patients with wet age-related macular degeneration (AMD) from a standard 2mg eye injection to a higher 8mg dose can help them go longer between treatments while keeping their vision stable. The research involves 50 patients who have already been receiving the standard treatment but may benefit from less frequent injections. Doctors will monitor vision and eye health over 12 months while gradually extending the time between injections when possible.